Hopa Rx

He could be American Board Certified in Internal Medicine and Medical Oncology. He is a member and serves in a number of committees at AACR, OLA, ESMO, ASCO, IASLC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, SLACOM, FLASCO, among other institutions.
She worked many years in retail before moving to Summit Cancer Centers in Spokane, WA as their Oral Chemotherapy Technician in their Medically Integrated Dispensary in 2018. In May of 2021, Summit Cancer Centers merged and became section of the American Oncology Network.

Her passions include symptom management, increasing usage of care, and improving the death literacy of communities through end-of-life education. She started her career in pediatric oncology and bone marrow transplant before looking after the adult oncology population in the outpatient sector. In her current role, Mary serves because the oral oncology nurse navigator for the Norton Cancer Institute. Paul may be the CPO for Florida Cancer Specialists with responsibilities and oversight for the in-clinic IV drugs and our Medically Integrated Oral Specialty Pharmacy.

Kirollos S Hanna, Pharmd, Bcop

She received her pharmacy degree from Ohio Northern University and completed her PGY1 and PGY2 Oncology Residency at Mayo Clinic in Rochester, MN. Ice is actively involved with patient care, research, and education. She actually is a board certified pharmacist in pharmacotherapy and oncology. Linda has been a pharmacist since 1981 when she received her PharmD degree at the University of Nebraska INFIRMARY in Omaha, Nebraska. She spent over 20 years as a hospital pharmacist, working in Med-Surg, ICU, and Oncology Services. Currently, Linda is working at Ironwood Research and Cancer Centers, also located in Phoenix, Arizona.

• Currently, she serves as the Director of Dispensing Services at The Ghosh Center IOD in Cedar Rapids Iowa.
• This session will review the clinical and economic impact of remote clinical reviews by
• He served as the Director of Outcomes Measurement and Research for Ohio State University Medical Center for 3 years.

Her previous experience includes community oncology, community pharmacy and pharmaceutical industry. At her previous community oncology medical group, Dr Taymuree developed and managed a MID together with infusion services. Yen obtained a BS from Texas A&M University in College Station and her PharmD from the University of Texas in Austin. Being a pharmacist for 20+ years, her pharmacy background contain PBMs, hospital, mail-order, retail chain, and community oncology. As a pharmacy manager at Kroger, she was awarded 3 years straight as the fastest growing pharmacy in sales for the Southwest Region of over 140+ stores. She then followed her passion of oncology by joining Oncology Consultants 16 years back as their in-office dispensing pharmacist.

Community Aspects

Texas Oncology, because the largest provider of oncology care in Texas, employs 420 physicians (med/onc, rad/onc, gyn/onc, urologists, and cancer surgeons) in 120 sites throughout the state. Oncology Pharmacy Services , owned by Texas Oncology, PA, has retail pharmacy operations in 40 of its sites.
Dr. Taymuree earned a BA from UC Berkeley and PharmD and MBA from the University of Maryland. Dr Taymuree happens to be employed as Oncology Manager, Pharmacy Services for Sutter Health, system wide. Sutter Health, a not for profit organization, serves over 100 communities and coordinated care to 3 million lives in Northern California. Dr Taymuree is responsible for managing Clinical Pathways, authoring guidelines and policies and developing pharmacy initiatives. She serves as the liaison for pharmacy between Sutter Health’s medical oncology providers and nursing.

• He could be American Board Certified in Internal Medicine and Medical Oncology.
• In 2016 he assisted in the establishment and currently manages Alabama Rx, a retail dispensing pharmacy for Alabama Oncology.
• Yen has extensive knowledge on GPOs, payer process, PBM contracts, pathways, etc.
• Despite recent advancement in the treating malignances, venous thromboembolism continues to be a source of morbidity and mortality in the cancer population.

Her research and scholarly activities focus on supportive care for people with cancer and multiple comorbidities, breast cancer, and the management of oral anticancer agents. Jessica Auten is really a clinical oncology pharmacist at the University of NEW YORK Medical Center in Chapel Hill, NC. Jessica received her PharmD degree from the UNC Eshelman School of Pharmacy. Dr. Egerton earned a BS from Niagara University and a BS and PharmD from the Albany College of Pharmacy. She attained her Board Certification in Oncology Pharmacy in 2006.
Prior to joining FCS he worked for ION Solutions in-may roles for the GOP including Account Manager, East Coast Director, and Director of Sales and Corporate Services, acting in many different capacities as the liaison between industry and clinical practices. Formerly, Paul was a published pathology researcher and previously a Financial Analyst for an oncology practice in NEW YORK.

Nancy J Egerton, Pharmd, Bcop

He serves on numerous local, state, and national boards, such as for example Community Oncology Alliance . He is a dynamic consultant and advisor to physician practices and pharmaceutical companies. Stuart received his MHA from Western Michigan University and MBA for the University of Colorado. Currently, Dr. Gordan serves because the president & managing physician of Florida Cancer Specialists & Research Institute and practices at the FCS Gainesville Cancer Center. He also serves as an associate of the board of directors for Community Oncology Alliance and Florida Association of Clinical Oncology . Dr. Lucio Gordan earned his medical degree from hawaii University of Londrina College of Medicine in Londrina, Brazil.
She hopes to work in either palliative care or oncology as she embraces her new role as a nurse practitioner. She lives in her hometown of Ventura, CA, where she actually is surrounded by family. Her nursing niche is oncology and palliative care, where she fiercely advocates for patients across the entire trajectory of cancer care, from diagnosis to survivorship or hospice.